Mupirocin lithium (Standard)

Overview

Mupirocin (lithium) (Standard) is the analytical standard of Mupirocin lithium ( HY-W108875 ). This product is intended for research and analytical applications. Mupirocin lithium is an antibiotic . Mupirocin lithium inhibits bacterial isoleucyl-tRNA synthetase , blocking protein synthesis. Mupirocin lithium has high activity against Gram-positive bacteria such as Staphylococcus and Streptococcus , as well as some Gram-negative bacteria (such as Haemophilus influenzae ). Mupirocin lithium can be used in the research of diseases such as skin infections (such as MRSA infections) and chronic sinusitis.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Aminoacyl-tRNA Synthetase

Product Information

• Catalog No.: HY-W108875R
• CAS No.: 73346-79-9
• Molecular Formula: C26H43LiO9
• Molecular Weight: 506.56
• Purity: 95%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source